DuPont de Nemours (DD) Earnings Analysis

DuPont de Nemours (DD) delivered mixed results in FY2026 on revenue of $56.6B versus the $56.6B estimate (+10.3% YoY) and EPS of $1.04. Below is the full DuPont de Nemours earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.

DuPont de Nemours (DD) Earnings Analysis — key stats

Next earnings dateFeb 6, 2025
Latest reported quarterFY2026
Earnings verdictMixed
Revenue$56.6B (vs $56.6B est · +0.0% surprise · +10.3% YoY)
EPS$1.04 (vs $0.96 est · +8.3% surprise · -10.4% YoY)
Share price$91.75 (+0.5%)
Market cap$1.16T

What you'll find

Frequently asked questions

When is DuPont de Nemours's next earnings date?
DuPont de Nemours's (DD) next scheduled earnings date is Feb 6, 2025. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did DuPont de Nemours (DD) beat or miss earnings?
In FY2026, DuPont de Nemours (DD) posted mixed results — revenue of $56.6B versus the $56.6B estimate (+0.0% surprise) and EPS of $1.04 versus $0.96 expected (+8.3% surprise). Magnisto decodes every DuPont de Nemours (DD) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
What is the forecast for DuPont de Nemours (DD) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for DuPont de Nemours (DD), anchored to the current $91.75 share price, so you can weigh the bull, base and bear cases for DuPont de Nemours side by side.
Is DuPont de Nemours (DD) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether DuPont de Nemours fits your own thesis and risk profile. This is research, not investment advice.

Related stocks

Educational research, not investment advice. Figures are illustrative and may be delayed.